Abstract
The paper is concerned with materials characterizing physicochemical properties of haemosorbents of varying grades. Adsorption of different uraemic toxins was studied. The possibility of microembolization of internal organs and tissues with haemosorbent particles was explored in the course of prolonged treatment with the use of haemosorption. Different approaches to connecting the sorption column to the dialyzer were examined to disclose an optimal variant. The authors report the results of applying haemosorption in patients who had received haemodialysis therapy to prevent complications. The blood response to the prolonged haemosorption treatment was analyzed. It is recommended that long-term (6–7 hours) sessions of haemosorption might be performed using carbons having high sorption capacity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dmitriev, A. A., Levitsky, E. R., Gorbovitsky, E. B.: Clinical use of hemosorbents of SKN type in the treatment of CRF.Klinicheskaya Medicina, 59, 71 (1981).
Ermolenko, V. M.: Chronic Hemodialysis. Moscow 1982.
Levitsky, E. R., Dmitriev, A. A., Plyaskina, A. W.: A programmed use of hemoperfusions through activated charcoal in the treatment of patients with terminal uremia.Terapevtitchesky Arkhiv, 11, 61 (1977).
Lopukhin, G. M., Molodenkov, M. N.: Hemoperfusion through Activated Charcoal. Moscow 1978.
Nicolaev, V. G., Strelko, W. W.: Hemocarboperfusion through Activated Charcoal. Kiev 1979.
Ryabov, S. I., Shostka, G. D., Lukichev, B. G., Strelko, V. V., Spiridonov, V. N., Babushkin, B. N., Kartel, N. T., Scherbitsky, A. B.: The use of hemoperfusion in combination with hemodialysis in the treatment of patients with chronic renal failure.Terapevtitchesky Arkhiv, 8, 15 (1981).
Shumakov, V. I., Levitsky, E. R., Dmitriev, A. A., Sakharova, N. N.: Hemoperfusion as a method of treatment of patients with chronic renal failure.Sovetskaya Medicina, 10, 95 (1977).
Shostka, G. D.: The relationship of anemia with blood losses and the present therapy in patients on hemodialysis.Terapevtitchesky Arkhiv, 8, 52 (1981).
Bergström, I., Fürst, P.: Uremic middle molecule.Clin. Nephrol., 5, 143 (1976).
Chang, T. M. S.: Artificial Cells. Illinois 1972.
Chang, T. M. S.: Assessments of clinical trials of charcoal hemoperfusion in uremic patients.Clin. Nephrol., 2, 111 (1979).
Chang, T. M. S., Chirito, E., Barre, P., Cole, C., Hewish, M.: Clinical performance characteristics of a new combined system for simultaneous hemoperfusion-hemodialysis-ultrafiltration in series.Trans. ASAJO, 21, 502 (1975).
Chang, T. M. S., Migchelsen, M., Coffey, J. E., Stark, K.: Serum middle molecule levels in uremia during long-term intermittent hemoperfusions with the AcAc (coated charcoal) microcapsule artificial kidney.Trans. Am. Soc. Artif. Intern. Organs, 20, 364 (1974).
Demitteenare, M. N., Maher, J. F., Schreiner, G. E.: Hemoperfusion through a charcoal column for glutethimide poisoning.trans. ASAJO, 13, 190 (1967).
Dunea, G., Kolff, W. J.: Clinical experiments with the Yatzidis charcoal artificial kidney.Trans. ASAJO, 11, 179 (1965).
Hagstam, K. E., Larsson, L. E., Thyseel, H.: Experimental studies on charcoal hemoperfusion in phenobarbital intoxication and uremia including histopathological findings.Acta Med. Scand., 180, 593 (1966).
Odaka, M., Ko Bajashi, H., Tabata, J., Soma, M.: Three hour maintenance dialysis combined with direct hemoperfusion and hemodialysis.Proc. Eur. Dial. Transpl. Ass., 13, 257 (1976).
Finch, C. A., Doubelbeis, K., Cook, J. D.: Ferrokinetics in man.Medicine (Baltimore),49, 15 (1970).
Siemsen, A. W., Dunea, G., Mandani, B. N., Guruprakash, G.: Charcoal hemoperfusion for chronic renal failure.Nephron, 22, 386 (1978).
Strelko, V. V., Korovin, Yu. F., Nikolaev, V. G., Adamenko, N. P.: Uncoated carbon sorbent SCN for hemoperfusion. Proc. 4th Intern. Symposium of Hemoperfusion and Artificial Organs. Ankara 1982, p. 144.
Winchester, J. F., Apiliga, M. T., Kennedy, A. D.: Short-term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients.Kidney Int., 10, 315 (1976).
Wing, A. J., Brunner, F. P., Chantler, C.: Combined report on regular dialysis and transplantation in Europe.Proc. Eur. Dial. Transpl. Ass., 15, 2 (1978).
Yatzidis, H.: A convenient hemoperfusion micro-apparatus over charcoal for the treatment of endogenous intoxications.Proc. Eur. Dial. Transpl. Ass., 1, 83 (1964).
Yatzidis, H., Yulis, G., Digenis, P.: Hemocarboperfusion-hemodialysis treatment in terminal renal failure.Kidney Int., 10, 312 (1976).
Smith, C.: Degradation of uric acid and 3-ribosyluric acid during treatment with charcoal.Microchem. J., 26, 387 (1981).
Smith, R. C., Affrossman, S., Courtney, J. M.: The catalytic oxidation of creatinine by activated carbon.Carbon, 17, 149 (1979).
Kushakovsky, M. S.: Clinical Forms of Hemoglobin Damage. Leningrad 1968, p. 23.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ryabov, S.I., Shostka, G.D., Lukichev, B.G. et al. Haemoperfusion in the treatment of chronic renal failure in patients on haemodialysis. International Urology and Nephrology 16, 345–360 (1984). https://doi.org/10.1007/BF02081871
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02081871